Beese Fulmer Investment Management’s Gilead Sciences GILD Stock Holding History

Beese Fulmer Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,398	Closed	-$417K	–	452
2025 Q4	$417K	Buy	3,398 +123	+4%	+$14.9K	0.03%	223
2025 Q3	$364K	Sell	3,275 -3	-0.1%	-$341	0.03%	221
2025 Q2	$363K	Buy	3,278 +967	+42%	+$103K	0.03%	217
2025 Q1	$259K	Hold	2,311	–	–	0.02%	210
2024 Q4	$213K	Buy	+2,311	New	+$208K	0.02%	215
2023 Q2	–	Sell	-2,590	Closed	-$215K	–	222
2023 Q1	$215K	Sell	2,590 -18	-0.7%	-$1.49K	0.02%	206
2022 Q4	$224K	Buy	+2,608	New	+$207K	0.03%	204
2020 Q3	–	Sell	-2,180	Closed	-$168K	–	331
2020 Q2	$168K	Buy	+2,180	New	+$167K	0.02%	198

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Beese Fulmer Investment Management's GILD Position: Q1 2026 in Review

Beese Fulmer Investment Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 3,398 shares — an estimated $417K sold.

Beese Fulmer Investment Management first reported a position in GILD in Q2 2020 and held it in 8 quarters. The position peaked at $417K in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Beese Fulmer Investment Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Beese Fulmer Investment Management sold 3,398 Gilead Sciences shares in Q1 2026, an estimated $417K.
Beese Fulmer Investment Management first reported a position in Gilead Sciences in Q2 2020 and held it in 8 quarters.
Beese Fulmer Investment Management's Gilead Sciences position peaked at $417K in Q4 2025.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q1 2026, filed 16 Apr 2026.